PRKD3 and neoplasm: Interestingly, tumor-intrinsic PKD3 has been described to promote immune escape by enhancing expression of Fas and PD-L1 as well as secretion of TGF-β, CCL-21 and IL-10, all of which are critical to establish an immunosuppressive tumor microenvironment [32, 33].